Physiologic variability of single-voxel proton MR spectroscopic measurements at 3T

American Journal of Neuroradiology

Volumn 26, Issue 3, 2005, Pages 585-590

  Wellard, R Mark ^a   Briellmann, Regula S ^a   Jennings, Claire ^a   Jackson, Graeme D ^a  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INOSITOL; ASPARTIC ACID; DRUG DERIVATIVE; GLUTAMIC ACID; GLUTAMINE; N ACETYLASPARTIC ACID; N-ACETYLASPARTATE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; INTERMETHOD COMPARISON; MALE; NEUTRON ACTIVATION ANALYSIS; NORMAL HUMAN; PHANTOM; PROTON NUCLEAR MAGNETIC RESONANCE; TEMPORAL LOBE; BIOLOGICAL MODEL; BRAIN; CALIBRATION; COMPARATIVE STUDY; EVALUATION; FRONTAL LOBE; IMAGE QUALITY; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OSMOLARITY; REFERENCE VALUE; REPRODUCIBILITY; TIME;

ADULT; ASPARTIC ACID; BRAIN; CALIBRATION; FEMALE; FRONTAL LOBE; GLUTAMIC ACID; GLUTAMINE; HUMANS; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MODELS, BIOLOGICAL; OSMOLAR CONCENTRATION; PHANTOMS, IMAGING; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; TEMPORAL LOBE; TIME FACTORS;

EID: 16844361954     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kuzniecky R. Magnetic resonance spectroscopy in focal epilepsy: 31P and 1H spectroscopy. Rev Neurol (Paris) 1999;155:495-498
2. Kuzniecky R, Hugg JW, Hetherington H. Relative utility of 1H spectroscopic imaging and hippocampal volumetry in the lateralization of mesial temporal lobe epilepsy. Neurology 1998;51:66-71
3. Kikuchi S, Kubota F, Akata T, et al. A study of the relationship between the seizure focus and 1H-MRS in temporal lobe epilepsy and frontal lobe epilepsy. Psychiatry Clin Neurosci 2000;54:455-459
4. Li LM, Cendes F, Antel SB, et al. Prognostic value of proton magnetic resonance spectroscopic imaging for surgical outcome in patients with intractable temporal lobe epilepsy and bilateral hippocampal atrophy. Ann Neurol 2000;47:195-200
5. Capizzano AA, Vermathen P, Laxer KD, et al. Multisection proton MR spectroscopy for mesial temporal lobe epilepsy. AJNR Am J Neuroradiol 2002;23:1359-1368
6. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993;13:981-989
7. Nonaka M, Kohmura E, Yamashita T, et al. Kainic acid-induced seizure upregulates Na(+)/myo-inositol cotransporter mRNA in rat brain. Brain Res Mol Brain Res 1999;70:179-186
8. Danielsen ER, Ross B. Magnetic Resonance Spectroscopy of Neurological Diseases. New York: Marcel Dekker; 1999
9. Wellard RM, Briellmann RS, Prichard JW, Syngeniotis A, Jackson GD. Myoinositol abnormalities in temporal lobe epilepsy. Epilepsia 2003;44:815-821
10. Marshall I, Wardlaw J, Cannon J, Slattery J, Sellar RJ. Reproducibility of metabolite peak areas in 1H MRS of brain. Magn Reson Imaging 1996;14:281-292
11. Bertolino A, Callicott JH, Nawroz S, et al. Reproducibility of proton magnetic resonance spectroscopic imaging in patients with schizophrenia. Neuropsychopharmacology 1998;18:1-9
12. Brooks WM, Friedman SD, Stidley CA. Reproducibility of 1H-MRS in vivo. Magn Reson Med 1999;41:193-197
13. Hoshino Y, Yoshikawa K, Inoue Y, et al. Reproducibility of short echo time proton magnetic resonance spectroscopy using point-resolved spatially localized spectroscopy sequence in normal human brains. Radiat Med 1999;17:115-120
14. Bartha R, Drost DJ, Menon RS, Williamson PC. Comparison of the quantification precision of human short echo time (1)H spectroscopy at 1.5 and 4.0 Tesla. Magn Reson Med 2000;44:185-192
15. Maton B, Londono A, Sawrie S, Knowlton R, denHollander J, Kuzniecky R. Reproducibility of proton magnetic resonance spectroscopy imaging measurements of normal human hippocampus at 1.5 T: clinical implications. J Neuroimaging 2001;11:194-201
16. Hsu YY, Chen MC, Lim KE, Chang C. Reproducibility of hippocampal single-voxel proton MR spectroscopy and chemical shift imaging. AJR Am J Roentgenol 2001;176:529-536
17. Li BS, Babb JS, Sober BJ, Maudsley AA, Gonen O. Reproducibility of 3D proton spectroscopy in the human brain. Magn Reson Med 2002;47:439-446
18. Binesh N, Yue K, Fairbanks L, Thomas MA. Reproducibility of localized 2D correlated MR spectroscopy. Magn Reson Med 2002;48:942-948
19. Chard DT, McLean MA, Parker GJ, MacManus DG, Miller DH. Reproducibility of in vivo metabolite quantification with proton magnetic resonance spectroscopic imaging. J Magn Reson Imaging 2002;15:219-225
20. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-679
21. Barker PB, Hearshen DO, Boska MD. Single-voxel proton MRS of the human brain at 1.5T and 3.0T. Magn Reson Med 2001; 45:765-769
22. de Graaf R, ed. In Vivo NMR Spectroscopy. New York: John Wiley & Sons, 1998:95
23. Wansapura JP, Holland SK, Dunn RS, Ball WS Jr. NMR relaxation times in the human brain at 3.0 tesla. J Magn Reson Imaging 1999;9:531-538